Drug developers rawn to orphan drugs market
Breakthrough therapies for rare diseases command premium pricing, particularly if no alternatives exist
31-Mar-2014 -
The global orphan drugs market presents plenty of opportunities for new drug development – while there are only 172 approved orphan therapies, over 6,800 orphan diseases exist according to the United States National Institute of Health (NIH). Advancements in drug discovery capabilities coupled ...
drug development
drug discovery
Frost & Sullivan
+7